Vivani Medical, Inc.: Vivani Medical Announces $8.25M Private Placement Equity Financing
Financing strengthens balance sheet, extending expected runway into the second quarter of 2026 Enables accelerated development of NPM-139, Company's once or twice-yearly GLP-1 (semaglutide) implant ...
Vivani Medical prices 7.4M shares at $1.12 in private placement financing
Vivani Medical (VANI) has entered into a securities purchase agreement to issue and sell an aggregate of 7,366,071 shares, each at a price of ...
Vivani Medical Announces $8.25M Private Placement Equity Financing
Financing strengthens balance sheet, extending expected runway into the second quarter of 2026 Enables accelerated ...
Stocktwits on MSN3d
Vivani Medical Announces Promising Preclinical Weight Loss Data For Its Semaglutide Implant: Retail Sentiment Soars
Vivani Medical, Inc. (VANI), on Wednesday, announced promising preclinical data for its semaglutide implant in development ...
Vivani Medical Gives Data for Weight Loss Implant
By Karen Roman Vivani Medical, Inc. (Nasdaq: VANI) announced positive data for NPM-139, its subdermal semaglutide implant for ...
Vivani Withers on Data Release
Vivani Medical, Inc. (NASDAQ: VANI) shares dropped in price Wednesday, as the Alameda, Calif.-based clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, ...
Vivani Medical Announces Positive Preclinical Weight Loss Data for NPM-139 Semaglutide Implant, with Potential for Once-Yearly Dosing
NanoPortal™ technology successfully delivers semaglutide, the active ingredient in Ozempic®/Wegovy®, in a preclinical study ...
Le Lézard5d
Smartkem Signs Memorandum of Understanding with RiTdisplay to Integrate Smartkem's OTFT Process Into Its Gen2.5 Line
Smartkem , which is seeking to change the world of electronics with a new class of transistor technology, has announced a memorandum of understanding with RiTdisplay Corporation, a leading developer ...
Le Lézard5d
America's Silent Epidemic Worsens: Adverse Drug Events Now the Third Leading Cause of Death
In 2021, the American Society of Pharmacovigilance (ASP) launched the Fourth Cause Campaign to raise awareness that adverse drug events (ADEs) were the fourth leading cause of death in the United ...
Vivani Medical (VANI) Expected to Announce Quarterly Earnings on Tuesday
Vivani Medical (NASDAQ:VANI – Get Free Report) is expected to be issuing its quarterly earnings data before the market opens on Tuesday, March 25th. Analysts expect the company to announce earnings of ...
clinicaltrialsarena10d
Omnipod 5 improves glycaemic levels in people transitioning from daily injections
Meanwhile, Vivani Medical has implanted the first patient with its weight loss device. Give your business an edge with our leading industry insights. Give your business an edge with our leading ...
HC Wainwright Lowers Earnings Estimates for Vivani Medical
HC Wainwright reduced their FY2024 earnings estimates for shares of Vivani Medical in a note issued to investors on Thursday, March 13th. HC Wainwright analyst Y. Chen now forecasts that the company ...